Recent developments in diagnosing bile acid diarrhea

References

• Camilleri M. Bile acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver. 2015;9(3):332–339. doi:10.5009/gnl14397
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Taylor A, et al. Combined fasting serum C4 and primary bile acids from a single stool sample to diagnose bile acid diarrhea. Gastroenterology. 2020;159(5):1952–1954 e1952.
   PubMed Web of Science ®Google Scholar
• BouSaba J, Sannaa W, McKinzie S, et al. Impact of bile acid diarrhea in patients with diarrhea-predominant irritable bowel syndrome on symptoms and quality of life. Clin Gastroenterol Hepatol. 2022;20(9):2083–2090 e2081. doi: 10.1016/j.cgh.2021.11.035
   PubMed Web of Science ®Google Scholar
• Sadowski DC, Camilleri M, Chey WD, et al. Canadian Association of Gastroenterology clinical practice guideline on the management of bile acid diarrhea. J Can Assoc Gastroenterol. 2020;3(1):e10–e27.
   PubMedGoogle Scholar
• Smalley W, Falck-Ytter C, Carrasco-Labra A, et al. AGA clinical practice guidelines on the laboratory evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults (IBS-D). Gastroenterology. 2019;157(3):851–854. doi:10.1053/j.gastro.2019.07.004
   PubMed Web of Science ®Google Scholar
• Marasco G, Cremon C, Barbaro MR, et al. Pathophysiology and clinical management of bile acid diarrhea. J Clin Med. 2022;11(11):3102. doi: 10.3390/jcm11113102
   PubMed Web of Science ®Google Scholar
• Camilleri M. Bile acid detergency: permeability, inflammation, and effects of sulfation. Am J Physiol Gastrointest Liver Physiol. 2022;322(5):G480–G488. doi:10.1152/ajpgi.00011.2022
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JYL. Bile acids as metabolic regulators: an update. Curr Opin Gastroenterol. 2023;39(3):249–255. doi:10.1097/MOG.0000000000000934
   PubMed Web of Science ®Google Scholar
• Chiang JY. Bile acids: regulation of synthesis. J Lipid Res. 2009;50(10):1955–1966. doi:10.1194/jlr.R900010-JLR200
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M. Current practice in the diagnosis of bile acid diarrhea. Gastroenterology. 2019;156(5):1233–1238. doi:10.1053/j.gastro.2018.11.069
   PubMed Web of Science ®Google Scholar
• Camilleri M, Vijayvargiya P. The role of bile acids in chronic diarrhea. Am J Gastroenterol. 2020;115(10):1596–1603. doi:10.14309/ajg.0000000000000696
   PubMed Web of Science ®Google Scholar
• Camilleri M, Shin A, Busciglio I, et al. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 2014;307(5):G508–516. doi: 10.1152/ajpgi.00178.2014
   PubMed Web of Science ®Google Scholar
• Balesaria S, Pattni SS, Johnston IM, et al. Common genetic variants in the bile acid synthesis Enzyme CYP7A1 are associated with severe primary bile acid diarrhea. Gastroenterology. 2022;163(2):517–519 e512. doi:10.1053/j.gastro.2022.05.005
   PubMed Web of Science ®Google Scholar
• Camilleri M, Nurko S. Bile Acid Diarrhea in Adults and Adolescents. Neurogastroenterol Motil. 2022;34(4):e14287. doi:10.1111/nmo.14287
   PubMed Web of Science ®Google Scholar
• Qie D, Zhang Y, Gong X, et al. SLC10A2 deficiency-induced congenital chronic bile acid diarrhea and stunting. Mol Genet Genomic Med. 2021;9(8):e1740. doi: 10.1002/mgg3.1740
   PubMed Web of Science ®Google Scholar
• Lee JM, Ong JR, Vergnes L, et al. Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants. J Lipid Res. 2018;59(3):429–438. doi: 10.1194/jlr.M078279
   PubMed Web of Science ®Google Scholar
• Camilleri M. Editorial: dissecting molecular mechanisms in bile acid diarrhea. Am J Gastroenterol. 2016;111(3):433–435. doi:10.1038/ajg.2016.23
   PubMed Web of Science ®Google Scholar
• BouSaba J, Camilleri M. Bile acid diarrhea - as bad as it gets? Curr Opin Gastroenterol. 2023;39(3):184–191. doi:10.1097/MOG.0000000000000916
   PubMed Web of Science ®Google Scholar
• Wong BS, Camilleri M, Carlson P, et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol. 2012;10(9):1009–1015 e1003. doi: 10.1016/j.cgh.2012.05.006
   PubMed Web of Science ®Google Scholar
• Johnston IM, Nolan JD, Pattni SS, et al. Characterizing factors associated with differences in FGF19 blood levels and synthesis in patients with primary bile acid diarrhea. Am J Gastroenterol. 2016;111(3):423–432. doi: 10.1038/ajg.2015.424
   PubMed Web of Science ®Google Scholar
• Fromm H, Malavolti M. Bile acid-induced diarrhoea. Clin Gastroenterol. 1986;15(3):567–582. doi:10.1016/S0300-5089(21)00739-2
   PubMedGoogle Scholar
• Vijayvargiya P, Gonzalez Izundegui D, Calderon G, et al. Increased fecal bile acid excretion in a significant subset of patients with other inflammatory diarrheal diseases. Dig Dis Sci. 2022;67(6):2413–2419. doi: 10.1007/s10620-021-06993-5
   PubMed Web of Science ®Google Scholar
• Valentin N, Camilleri M, Altayar O, et al. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis. Gut. 2016;65(12):1951–1959. doi: 10.1136/gutjnl-2015-309889
   PubMed Web of Science ®Google Scholar
• Bjørnbak C, Engel PJH, Nielsen PL, et al. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther. 2011;34(10):1225–1234. doi:10.1111/j.1365-2036.2011.04865.x
   PubMed Web of Science ®Google Scholar
• Appleby RN, Moghul I, Khan S, et al. Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: a prospective observational study. PLoS One. 2019;14(1):e0211348. doi: 10.1371/journal.pone.0211348
   PubMed Web of Science ®Google Scholar
• Scarpello JH, Hodgson E, Howlett HC. Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus. Diabet Med. 1998;15(8):651–656. doi:10.1002/(SICI)1096-9136(199808)15:8<651:AID-DIA628>3.0.CO;2-A
   PubMed Web of Science ®Google Scholar
• Bannaga A, Kelman L, O’Connor M, et al. How bad is bile acid diarrhoea: an online survey of patient-reported symptoms and outcomes. BMJ Open Gastroenterol. 2017;4(1):e000116. doi:10.1136/bmjgast-2016-000116
   PubMed Web of Science ®Google Scholar
• Sciarretta G, Vicini G, Fagioli G, et al. Use of 23-selena-25-homocholyltaurine to detect bile acid malabsorption in patients with ileal dysfunction or diarrhea. Gastroenterology. 1986;91(1):1–9. doi:10.1016/0016-5085(86)90431-2
   PubMed Web of Science ®Google Scholar
• Wedlake L, A’Hern R, Russell D, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2009;30(7):707–717. doi: 10.1111/j.1365-2036.2009.04081.x
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Chedid V, et al. Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea. Clin Gastroenterol Hepatol. 2019;17(5):922–929 e922. doi: 10.1016/j.cgh.2018.05.050
   PubMed Web of Science ®Google Scholar
• Kumar A, Al-Hassi HO, Jain M, et al. A single faecal bile acid stool test demonstrates potential efficacy in replacing SeHCAT testing for bile acid diarrhoea in selected patients. Sci Rep. 2022;12(1):8313.
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Carlson P, et al. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther. 2017;46(6):581–588. doi: 10.1111/apt.14214
   PubMed Web of Science ®Google Scholar
• Borup C, Hansen SH, Munck LK. Correction to: biochemical diagnosis of bile acid diarrhea: prospective comparison with the 75Seleno-taurohomocholic acid test. Am J Gastroenterol. 2022;117(11):1885–1886. doi:10.14309/ajg.0000000000001969
   PubMed Web of Science ®Google Scholar
• Borup C, Vinter-Jensen L, Jørgensen SP, et al. Combining single stool and plasma biochemical tests match the 23-(75se)-selena-taurohomocholic acid retention test for bile acid diarrhea: an exploratory diagnostic accuracy study. Gastroenterology. 2023;164(6, Supplement):S–1062.
   Web of Science ®Google Scholar
• Brydon WG, Nyhlin H, Eastwood MA, et al. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996;8(2):117–123. doi:10.1097/00042737-199602000-00005
   PubMed Web of Science ®Google Scholar
• Chang C, Jiang J, Sun R, et al. Downregulation of serum and distal ileum fibroblast growth Factor19 in bile acid diarrhoea patients. Dig Dis Sci. 2022;67(3):872–879. doi:10.1007/s10620-021-07042-x
   PubMed Web of Science ®Google Scholar
• Lyutakov I, Ursini F, Penchev P, et al. Methods for diagnosing bile acid malabsorption: a systematic review. BMC Gastroenterol. 2019;19(1):185. doi: 10.1186/s12876-019-1102-1
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Kane JS, Mumtaz S, et al. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil. 2012;24(11):983–e538. doi:10.1111/j.1365-2982.2012.01953.x
   PubMed Web of Science ®Google Scholar
• Khanna L, Halfdanarson TR, Sonbol MB, et al. Bile acid malabsorption in patients with neuroendocrine tumors. Dig Dis Sci. 2022;67(6):2517–2525. doi:10.1007/s10620-021-07189-7
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Gonzalez Izundegui D, Calderon G, et al. Fecal bile acid testing in assessing patients with chronic unexplained diarrhea: implications for healthcare utilization. Am J Gastroenterol. 2020;115(7):1094–1102. doi: 10.14309/ajg.0000000000000637
   PubMed Web of Science ®Google Scholar
• Theriot CM, Bowman AA, Young VB, et al. Antibiotic-induced alterations of the Gut microbiota alter secondary bile acid production and allow for clostridium difficile spore germination and outgrowth in the large intestine. mSphere. 2016;1(1). doi: 10.1128/mSphere.00045-15
   PubMed Web of Science ®Google Scholar
• Camilleri M, Acosta A, Busciglio I, et al. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2015;41(5):438–448. doi: 10.1111/apt.13065
   PubMed Web of Science ®Google Scholar
• Eusufzai S, Axelson M, Angelin B, et al. Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test. Gut. 1993;34(5):698–701.
   PubMed Web of Science ®Google Scholar
• Borup C, Wildt S, Rumessen J, et al. Biochemical diagnosis of bile acid diarrhea: prospective comparison with the 75Seleno-taurohomocholic acid test. Am J Gastroenterol. 2020;115(12):2086–2094. doi: 10.14309/ajg.0000000000000772
   PubMed Web of Science ®Google Scholar
• Battat R, Duijvestein M, Vande Casteele N, et al. Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one are associated with bile acid diarrhea in patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2019;17(13):2722–2730 e2724. doi: 10.1016/j.cgh.2018.11.012
   PubMed Web of Science ®Google Scholar
• BouSaba J, Torres M, Dilmaghani S, et al. Effects of FGF19 analogue aldafermin in patients with bile acid diarrhea: a randomized, placebo-control trial. Gastroenterology. 2023;165(2):499–501 e494. doi:10.1053/j.gastro.2023.04.007
   PubMed Web of Science ®Google Scholar
• Pattni SS, Brydon WG, Dew T, et al. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment Pharmacol Ther. 2013;38(8):967–976. doi: 10.1111/apt.12466
   PubMed Web of Science ®Google Scholar
• Orekoya O, McLaughlin J, Leitao E, et al. Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy. Clin Med. 2015;15(4):371. doi:10.7861/clinmedicine.15-4-371
   PubMed Web of Science ®Google Scholar
• Costa S, Gattoni S, Nicolardi ML, et al. Prevalence and clinical features of bile acid diarrhea in patients with chronic diarrhea. J Dig Dis. 2021;22(2):108–112. doi: 10.1111/1751-2980.12969
   PubMed Web of Science ®Google Scholar
• McKenzie YA, Sremanakova J, Todd C, et al. Effectiveness of diet, psychological, and exercise therapies for the management of bile acid diarrhoea in adults: a systematic review. J Hum Nutr Diet. 2022;35(6):1087–1104. doi:10.1111/jhn.13005
   PubMed Web of Science ®Google Scholar
• Borup C, Vinter-Jensen L, Jørgensen SPG, et al. Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial. Lancet Gastroenterol Hepatol. 2023;8(4):321–331.
   PubMed Web of Science ®Google Scholar
• Appleby RN, Bajor A, Gillberg PG, et al. Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea. United Eur Gastroenterol J. 2017;5(3):380–388. doi: 10.1177/2050640616662432
   PubMed Web of Science ®Google Scholar
• Beigel F, Teich N, Howaldt S, et al. Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn’s disease: a randomized, double-blind, placebo-controlled study. J Crohn's Colitis. 2014;8(11):1471–1479. doi: 10.1016/j.crohns.2014.05.009
   Google Scholar
• Fernandez-Banares F, Rosinach M, Piqueras M, et al. Randomised clinical trial: colestyramine vs. hydroxypropyl cellulose in patients with functional chronic watery diarrhoea. Aliment Pharmacol Ther. 2015;41(11):1132–1140. doi: 10.1111/apt.13193
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Carlson P, et al. Effects of colesevelam on bowel symptoms, biomarkers, and colonic mucosal gene expression in patients with bile acid diarrhea in a randomized trial. Clin Gastroenterol Hepatol. 2020;18(13):2962–2970 e2966. doi: 10.1016/j.cgh.2020.02.027
   PubMed Web of Science ®Google Scholar
• Walters JR, Johnston IM, Nolan JD, et al. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid. Aliment Pharmacol Ther. 2015;41(1):54–64. doi:10.1111/apt.12999
   PubMed Web of Science ®Google Scholar
• Kårhus ML, Brønden A, Forman JL, et al. Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial. Lancet Gastroenterol Hepatol. 2022;7(10):922–931. doi: 10.1016/S2468-1253(22)00198-4
   PubMed Web of Science ®Google Scholar
• Zhan K, Zheng H, Li J, et al. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome. Biomed Res Int. 2020;2020:3828249.
   PubMedGoogle Scholar
• Zhao L, Yang W, Chen Y, et al. A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome. J Clin Invest. 2020;130(1):438–450. doi: 10.1172/JCI130976
   PubMed Web of Science ®Google Scholar
• Camilleri M, Sellin JH, Barrett KE. Pathophysiology, evaluation, and management of chronic watery diarrhea. Gastroenterology. 2017;152(3):515–532 e512.
   PubMed Web of Science ®Google Scholar